As people begin to travel and gather for the holidays, experts are warning of a fifth wave of COVID-19 cases. According to the Centers for Disease Control and Prevention, the omicron variant now accounts for most of the new coronavirus cases in Georgia.
The turnaround came in the wake of a fifth wave of infections that peaked in August. Japan is trying to figure out why its COVID case numbers and fatalities have plummeted.
From India to Israel to white-tailed deer in Iowa harboring the coronavirus, our top COVID stories of the year reveal the ever-changing nature of the world's health crisis.
Researchers in South Africa have found that people infected with omicron, on average, are less likely to end up in the hospital. But the variant may act differently here in the U.S.
In a sweeping interview with GPB News, Commissioner of Public Health Kathleen Toomey touched on everything from the emotional toll the pandemic has taken on public health staff to widespread vaccine hesitancy across all racial groups in Georgia.
Since Lindsay rolled up her sleeve to get vaccinated a year ago, she has devoted herself to motivating others, especially those who are hesitant, to get vaccinated. She shares five persuasive tips.
More than 400 people who died of COVID were secretly interred in a mass grave on the outskirts of the city of Iquitos. Families are demanding a proper burial for their loved ones.
Friday on Political Rewind: We looked at the latest news about the coronavirus. We tackled your questions about the new omicron variant, and where it is likely is it to become the dominant strain of COVID in Georgia. How will schools, public spaces and travel change in the coming months?
Protein subunit vaccines work by injecting people with a tiny portion of a virus. In the case of the COVID-19 vaccine, that tiny portion is the spike protein that the coronavirus uses to enter cells.
Pfizer's CEO says the vaccine maker has asked federal regulators to authorize boosters for 16- and 17-year-olds. Currently, only people 18 and over are eligible for a booster in the U.S.
If the Food and Drug Administration authorizes use of the drug, called molnupiravir, it would be the first oral COVID-19 treatment that could be taken at home.
